Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death [figure presented]

Rong Na, S. Lilly Zheng, Misop Han, Hongjie Yu, Deke Jiang, Sameep Shah, Charles M. Ewing, Liti Zhang, Kristian Novakovic, Jacqueline Petkewicz, Kamalakar Gulukota, Donald L. Helseth, Margo Quinn, Elizabeth Humphries, Kathleen E. Wiley, Sarah D. Isaacs, Yishuo Wu, Xu Liu, Ning Zhang, Chi Hsiung WangJanardan Khandekar, Peter J. Hulick, Daniel H. Shevrin, Kathleen A. Cooney, Zhoujun Shen, Alan W. Partin, H. Ballentine Carter, Michael A. Carducci, Mario A. Eisenberger, Sam R. Denmeade, Michael McGuire, Patrick C. Walsh, Brian T. Helfand, Charles B. Brendler, Qiang Ding, Jianfeng Xu, William B. Isaacs

Research output: Contribution to journal › Article › peer-review

128 Scopus citations

Fingerprint

Dive into the research topics of 'Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death [figure presented]'. Together they form a unique fingerprint.

Medicine & Life Sciences